Elaiapharm is a finished-dose manufacturer based in France. It appears in 15 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with EDE (AE), MINSA (CR) and INVIMA (CO). Its GMP standing is certified by ANSM (FR), EMA and ANVISA (Brazil).
| Site | FDA FEI |
|---|---|
| Valbonne, United Arab Emirates | Not on file |
| France, France | 3005659648 |
| VALBONNE, France | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| EDE (AE) | 8 | None |
| MINSA (CR) | 6 | None |
| INVIMA (CO) | 1 | None |
| ANSM (FR) | None | 3 |
| EMA | None | 1 |
| ANVISA (Brazil) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $43.2M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Elaiapharm comes back tiered against every other supplier able to file there.
Start for free